Cell/Gene Therapy Cost Recovery Options Could Include Pre-Approval Public ‘Bridge’ Funding

 
• By Kate Rawson
  
More cost recovery bridge funding could enhance rare disease drug development. (Shutterstock)

More from Cell & Gene Therapies

More from Rare Diseases